Job title: Menlo Therapeutics Inc.


Case Study by Menlo Therapeutics: Impacting Mega-Itch: Managing Intense Pruritus in Prurigo Nodularis Through NK1-Substance Neurotransmission Inhibition 11:45 am

• Understanding Prurigo Nodularis • Taking a step back: What is tachykinin-mediated neurobiology? • Exploring the development of the orally bioavailable neurokinin-1 receptor antagonist, Serlopitant • Showcasing phase III topline data from NULARIS-1 and NULARIS-2 studiesRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.